chrX-116172341-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000686.5(AGTR2):c.61G>A(p.Gly21Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000091 in 1,208,927 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G21V) has been classified as Likely benign.
Frequency
Consequence
NM_000686.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AGTR2 | NM_000686.5 | c.61G>A | p.Gly21Arg | missense_variant | 3/3 | ENST00000371906.5 | |
AGTR2 | NM_001385624.1 | c.61G>A | p.Gly21Arg | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AGTR2 | ENST00000371906.5 | c.61G>A | p.Gly21Arg | missense_variant | 3/3 | 1 | NM_000686.5 | P1 | |
AGTR2 | ENST00000681852.1 | c.61G>A | p.Gly21Arg | missense_variant | 2/2 | P1 | |||
AGTR2 | ENST00000680409.1 | n.529G>A | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.00000898 AC: 1AN: 111334Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33594
GnomAD4 exome AF: 0.00000911 AC: 10AN: 1097540Hom.: 0 Cov.: 31 AF XY: 0.00000826 AC XY: 3AN XY: 363076
GnomAD4 genome AF: 0.00000898 AC: 1AN: 111387Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33657
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 27, 2017 | The G21R variant in the AGTR2 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The G21R variant was not observed with any significant frequency in approximately 5300 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The G21R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not conserved, and in silico analysis predicts this variant likely does not alter the protein structure/function. We interpret G21R as a variant of uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at